Natco Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: NATCOPHARM BSE: 524816

₹821.50

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #39 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Natco Pharma Limited (this stock)	14,714	16.5	15.4%	0.8%	—	74	81	48

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹15,409 Cr

EV / EBITDA

13.5x

EV / Sales

5.14x

Market cap / Sales

4.91x

Earnings yield

6.06%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 645 Cr, down 48.5% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 75 Cr, down 83.9% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	597	102	75	₹4.1700
March 31, 2026	609	110	210	₹11.7000
Dec. 31, 2025	529	125	107	₹5.9700
Sept. 30, 2025	1,264	586	501	₹27.9700
June 30, 2025	1,193	543	464	₹25.9100
March 31, 2025	1,157	521	428	₹23.9000
Dec. 31, 2024	408	150	125	₹6.9700
Sept. 30, 2024	1,293	797	661	₹36.9100
June 30, 2024	1,237	758	636	₹35.5300
March 31, 2024	965	432	349	₹19.4900
Dec. 31, 2023	625	224	192	₹10.7200
Sept. 30, 2023	930	424	360	₹20.1100
June 30, 2023	1,048	475	405	₹22.4300

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	645	682	584	1,358	1,252	1,220	576	1,344	1,277	1,001	655	955	1,063
Operating revenue	597	609	529	1,264	1,193	1,157	408	1,293	1,237	965	625	930	1,048
Other income	48	73	55	93	60	62	168	51	40	36	30	25	15
Operating expenses	491	516	408	712	653	596	378	502	474	512	387	488	545
Operating profit	106	92	120	552	540	561	29	791	763	453	238	442	504
Operating profit margin	17.8%	15.2%	22.7%	43.7%	45.3%	48.5%	7.2%	61.2%	61.7%	46.9%	38.1%	47.5%	48.0%
Depreciation	43	46	42	48	54	94	44	42	40	52	40	40	40
Interest	10	10	8	12	3	9	3	3	4	4	4	3	3
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	102	110	125	586	543	521	150	797	758	432	224	424	475
Tax	27	-100	18	85	79	93	25	136	122	83	32	64	70
Net profit	75	—	107	501	464	428	125	661	636	349	192	360	405
EPS	4.17	11.70	5.97	27.97	25.91	23.90	6.97	36.91	35.53	19.49	10.72	20.11	22.43
Net profit (TTM)	—	—	1,500	1,518	1,678	1,850	1,771	1,838	1,538	1,307	1,212	1,057	734
EPS (TTM)	49.81	71.55	83.75	84.75	93.69	103.31	98.90	102.65	85.85	72.75	67.18	58.50	40.46

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	3,595	1,364	1,282
March 31, 2025	4,094	2,226	1,850
March 31, 2024	3,569	1,555	1,307
March 31, 2023	2,351	771	637

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	16.7%	17.2%	3,876^†	4,416^†	3,674^†	2,436^†	1,862^†	1,755^†	2,116^†	2,148^†	2,001^†
Operating revenue	15.2%	16.8%	3,595	4,094	3,569	2,351	1,768^†	1,654^†	1,986^†	2,108^†	1,988^†
Other income	—	—	281^†	321^†	105^†	86^†	95^†	101^†	130^†	39^†	13^†
Operating expenses	—	—	2,290^†	1,950^†	1,932^†	1,506^†	1,555^†	1,236^†	1,170^†	1,180^†	1,284^†
Operating profit	15.6%	25.6%	1,305^†	2,144^†	1,637^†	845^†	213^†	418^†	816^†	928^†	704^†
Operating profit margin	—	—	36.3%^†	52.4%^†	45.9%^†	35.9%^†	12.0%^†	25.3%^†	41.1%^†	44.0%^†	35.4%^†
Depreciation	—	—	190^†	220^†	172^†	151^†	138^†	115^†	80^†	66^†	54^†
Interest	—	—	32^†	20^†	14^†	9^†	13^†	11^†	19^†	15^†	17^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	21.0%	28.3%	1,364	2,226	1,555	771	156^†	392^†	847^†	888^†	634^†
Tax	—	—	83^†	376^†	249^†	134^†	17^†	83^†	180^†	189^†	139^†
Net profit	26.2%	32.9%	1,282	1,850	1,307	637	139^†	310^†	667^†	698^†	495^†
EPS	27.0%	33.3%	71.55^†	103.31^†	72.75^†	34.90^†	7.63^†	16.99^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Operating margin	36.3%^†	52.4%^†	45.9%^†	35.9%^†	12.0%^†	25.3%^†	41.1%^†	44.0%^†	35.4%^†
EBIT margin	38.8%^†	54.8%^†	44.0%^†	33.1%^†	9.6%^†	24.4%^†	43.6%^†	42.8%^†	32.8%^†
PBT margin	37.9%	54.4%	43.6%	32.8%	8.8%^†	23.7%^†	42.7%^†	42.1%^†	31.9%^†
Net margin	35.7%	45.2%	36.6%	27.1%	7.9%^†	18.7%^†	33.6%^†	33.1%^†	24.9%^†
Interest coverage	43.23x^†	114.57x^†	108.26x^†	90.62x^†	12.72x^†	35.71x^†	46.07x^†	61.38x^†	37.28x^†
Dividend payout	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—
Current ratio	2.76x	5.42x	—	—	—	—	—	—	—
Quick ratio	2.30x	4.68x	—	—	—	—	—	—	—
Debt to equity	0.08x	0.04x	—	—	—	—	—	—	—
Return on equity	15.0%	25.2%	—	—	—	—	—	—	—
Return on assets	12.5%	22.4%	—	—	—	—	—	—	—
Return on capital employed	16.0%^†	30.3%^†	—	—	—	—	—	—	—
Asset turnover	0.35x	0.50x	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	1,776	-2,078	302	383	1,393
March 31, 2025	1,662	-1,444	-212	404	1,258
March 31, 2024	1,196	-960	-237	334	862
March 31, 2023	800	-437	-345	142	657
March 31, 2022	58	-92	36	226	-168

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	10,287	8,553	8,517	606	100	4,320	1,566	12	2,520	724
March 31, 2025	8,270	7,334	7,298	273	0	4,688	865	11	2,410	642
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.